Modelling and managing the depressive disorders: A clinical guide

Modelling and Managing the Depressive Disorders: A Clinical Guide

Volumn , Issue , 2005, Pages 1-247

  Parker, Gordon ^a   Manicavasagar, Vijaya ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b BLACK DOG INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84929763474     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511544194     Document Type: Book

References (111)

1. Akiskal, H. S., … McKinney Jr., W. T. (1975). Overview of recent research in depression. Integration of ten conceptual models into a comprehensive clinical frame. Archives of General Psychiatry, 32(3), 285-305.
2. Altschule, M. D. (1967). The two kinds of depression according to St. Paul. British Journal of Psychiatry, 113, 779-780.
3. American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders (DSM-III) (3rd ed.). Washington, DC: American Psychiatric Association.
4. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (DSM-IV) (4th ed.). Washington, DC: American Psychiatric Association.
5. American Psychiatric Association. (2000). APA practice guidelines for the treatment of psychiatric disorders, compendium 2000. Washington, DC: American Psychiatric Association.
6. Anderson, I. M. (2000). Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. Journal of Affective Disorders, 58(1), 19-36.
7. Babyak, M., Blumenthal, J. A., Herman, S., Khatri, P., Doraiswamy, M., Moore, K., et al. (2000). Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosomatic Medicine, 62(5), 633-638.
8. Beck, A. T. (1983). Cognitive therapy of depression: New perspectives. In J. Barrett (Ed.), Treatment of depression: Old controversies and new approaches (pp. 265-290). New York, NY: Raven press.
9. Beck, A. T., Rush, A. J., Shaw, B. F., & Emery, G. (1979). Cognitive therapy of depression. New York, NY: Guilford.
10. Beckmann, H., Athen, D., Olteanu, M., & Zimmer, R. (1979). DL-phenylalanine versus imipramine: A double-blind study. Archiv fur Psychiatrie Nervenkrankheiten, 227, 49-58.
11. Benton, D., & Cook, R. (1991). The impact of selenium supplementation on mood. Biological Psychiatry, 29(11), 1092-1098.
12. Blashfield, R. K., & Morey, L. C. (1979). The classification of depression through cluster analysis. Comprehensive Psychiatry, 20, 516-527.
13. Boyce, P., & Parker, G. (1989). Development of a scale to measure interpersonal sensitivity. Australian & New Zealand Journal of Psychiatry, 23(3), 341-351.
14. Bryson, B. (2003). A short history of nearly everything. Sydney: Doubleday.
15. Carroll, B. J. (1989). Diagnostic validity and laboratory studies: rules of the game. In J. E. Barrett (Ed.), The validity of psychiatric diagnosis (pp. 229-245). New York, NY: Raven Press.
16. Costa, P. T., & McCrae, R. R. (1990). Personality disorders and the five-factor model of personality. Journal of Personality Disorders, 4(4), 362-371.
17. Costa, P. T., & McRae, R. R. (1992). Revised NEO personality inventory (NEO PI-R) and NEO five-factor inventory (NEO-FFI) professional manual. Odessa, FL: Psychological Assessment Resources.
18. Deveson, A. (2003). Resilience. Crows Nest: Allen & Unwin.
19. DHHS Depression Guideline Panel. (1993). Depression in primary care. Volume 2. Treatment of major depression. Rockville, MD: US Department of Health and Human Services. Public Health Service, Agency or Health Care Policy and Research.
20. Epstein, D., & White, M. (1992). Experience, contradiction, narrative and imagination. Selected papers of David Epstein and Michael White. Adelaide: Dulwich Centre Publications.
21. Erikson, E. H. (1995). Childhood and society (2nd ed.). London: Vintage.
22. Furman, B., & Ahola, T. (1994). Solution talk: the solution-oriented way of talking about problems. In M. F. Hoyt (Ed.), Constructive therapies. New York, NY: The Guilford Press.
23. Geertz, C. (1975). The interpretation of cultures. London: Hutchinson.
24. Gelenberg, A. J., Wojcik, J. D., Falk, W. E., Baldessarini, R. J., et al. (1990). Tyrosine for depression: A double-blind trial. Journal of Affective Disorders, 19(2), 125-132.
25. Goodwin, G. M., Anderson, I., Angst, J., Baldwin, D., Bhagwagar, Z., Cookson, J., et al. (2003). Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 17(2), 149-173.
26. Greyson, B. (1996). Distance healing of patients with major depression. Journal of Science Exploration, 10, 447-465.
27. Hadjipavlou, G., Mok, H., & Yatham, L. N. (2004). Bipolar II disorder: an overview of recent developments. Canadian Journal of Psychiatry, 49, 802-812.
28. Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neuroscience and Psychiatry, 23, 56.
29. Han, J. S. (1986). Electroacupuncture: an alternative to antidepressants for treating affective diseases? International Journal of Neuroscience, 29(1-2), 79-92.
30. Han, J. S., & Terenius, L. (1982). Neurochemical basis for acupuncture analgesia. Annual Review of Pharmacology and Toxicology, 22,193-220.
31. Himmelhoch, J. M. (2003). On the usefulness of clinical case studies: Commentary. Bipolar Disorders, 5(1), 69-71.
32. Holmes, J. (2002). All you need is cognitive behaviour therapy. British Medical Journal, 324, 288-294.
33. Hypericum Depression Trial Study Group. (2002). Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial. Journal of the American Medical Association, 287(14), 1807-1814.
34. Ivey, A. (1988). Intentional interviewing and counselling – facilitating client development (2nd ed.). California, CA: Brooks/Cole Publishing Company.
35. Jackson, S. W. (1986). Melancholia and depression: from hippocratic times to modern times. New Haven and London: Yale University Press.
36. Khan, A., Khan, S., & Brown, W. A. (2002). Are placebo controls necessary to test new antidepressants and anxiolytics? International Journal of Neuropsychopharmacology, 5(3), 193-197.
37. Kiloh, L. G., Andrews, G., Neilson, M., & Bianchi, G. N. (1972). The relationship of the syndromes called endogenous and neurotic depression. British Journal of Psychiatry, 121(561), 183-196.
38. Kirk, S. A., & Kutchins, H. (1992). The selling ofDSM: the rhetoric of science in psychiatry. New York, NY: Aldine de Gruyter.
39. Kirsch, I., Moore, T. J., Scoboria, A., & Nicholls, S. (2002). The Emperor's new drugs: An analysis of antidepressant medication data, submitted to the US Food and Drug Administration. Prevention and Treatment, 5,1-11.
40. Klerman, G. L., & Weissman, M. M. (1994). Interpersonal psychotherapy of depression. London: Jason Aronson, Inc.
41. Koenig, H. G. (1999). Religious attitudes and practices of hospitalized medically ill adults. International Journal of Geriatric Psychiatry, 13(4), 213-224.
42. Koenig, H. G., George, L. K., & Peterson, B. L. (1998). Religiosity and remission of depression in medically ill older patients. American Journal of Psychiatry, 155(4), 536-542.
43. Kripke, D. F. (1998). Light treatment for nonseasonal depression: speed, efficacy, and combined treatment. Journal of Affective Disorders, 49(2), 109-117.
44. Kruedelbach, N., McCormick, R. A., Schulz, S., & Grueneich, R. (1993). Impulsivity, coping styles, and triggers for craving in substance abusers with borderline personality disorder. Journal of Personality Disorders, 7(3), 214-222.
45. Lee, T. M. C., & Chan, C. C. H. (1999). Dose-response relationship of phototherapy for seasonal affective disorder: A meta-analysis. Acta Psychiatrica Scandinavica, 99(5), 315-323.
46. Lewis, A. J. (1931). A clinical and historical survey of depressive states based on the study of 61 cases. Unpublished Ph.D., University of Adelaide, Adelaide.
47. Linjaerde, O., Foreland, A. R., & Magnusson, A. (1999). Can winter depression be prevented by Ginkgo biloba extract? A placebo-controlled trial. Acta Psychiatrica Scandinavica, 100(1), 62-66.
48. Lipton, R. I. (1994). The effect of moderate alcohol use on the relationship between stress and depression. American Journal of Public Health, 84(12), 1913-1917.
49. Livesley, W., Jang, K. L., & Vernon, P. A. (1998). Phenotypic and genetic structure of traits delineating personality disorder. Archives of General Psychiatry, 55(10), 941-948.
50. Luo, H., Meng, F., Jia, Y., & Zhao, X. (1998). Clinical research on the therapeutic effect of electroacupuncture treatment in patients with depression. Psychiatry and Clinical Neuroscience, 52, 5338-5340.
51. Malhi, G. S., Lagopoulos, J., Ward, P. B., Kumari, V., Mitchell, P. B., Parker, G. B., et al. (2004). Cognitive generation of affect in bipolar depression: An fMRI study. European Journal of Neuroscience, 19(3), 741-754.
52. Mapother, E. (1926). Discussion on manic-depressive psychosis. British Medical Journal, 2, 872-879.
53. Matussek, P., Soeldner, M. L., & Nagel, D. (1982). Neurotic depression: results of cluster analysis. Journal of Nervous & Mental Disease, 170(10), 588-597.
54. McCrae, R. R., & Costa, P. T. (1985). Updating Norman's ‘adequacy taxonomy’: intelligence and personality dimensions in natural language questionnaires. Journal of Personality and Social Psychology, 49, 710-721.
55. Meltzer, H. (2004).Neuropsychopharmacology in the media: Did they get it right? CINP newsletter, 1-18.
56. Miller, W. R., & Rollnick, S. (1991). Motivational interviewing: Preparing people to change addictive behaviour. New York, NY: The Guilford Press.
57. Millon, T., & Davis, R. O. (1996). Disorders of personality: DSM-IV and beyond (2nd ed.). New York, NY: John Wiley & Sons.
58. Minter, R. E., & Mandel, M. R. (1979). The treatment of psychotic major depressive disorder with drugs and electroconvulsive therapy. Journal ofNervous & Mental Disease, 167, 726-733.
59. Mitchell, P. B., Parker, G. B., Gladstone, G. L., Wilhelm, K., & Austin, M.-P. V. (2003). Severity of stressful life events in first and subsequent episodes of depression: the relevance of depressive subtype. Journal of Affective Disorders, 73(3), 245-252.
60. Mitchell, P., Malhi, G., Redwood, B. L., & Ball, J. (2004). Australian and New Zealand clinical practice guideline for the treatment of bipolar disorder. Australia and New Zealand Journal of Psychiatry, 38, 280-305. Commonwealth Department of Health and Aged Care.
61. Nemets, B., Stahl, Z., & Belmaker, R. H. (2002). Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. American Journal of Psychiatry, 159(3), 477-479.
62. Parker, G. (1983). Parental overprotection. A risk factor in psychosocial development. London: Grune and Stratton, Inc.
63. Parker, G. (2001).‘New’ and ‘old’ antidepressants: All equal in the eyes of the lore? British Journal of Psychiatry, 179, 95-96.
64. Parker, G. (2004). Dealing with depression. A common sense guide to mood disorders. Sydney: Allen & Unwin. 2nd Ed.
65. Parker, G. (2004). Evaluating treatments for the mood disorders: Time for the evidence to get real. Australian & New Zealand Journal of Psychiatry, 38(6), 408-414.
66. Parker, G. (2005). Beyond major depression. Psychological Medicine, 35, 467-474.
67. Parker, G., & Gladstone, G. (2004). Capacity of the 10-item depression in the medically ill screening measure to detect depression ‘caseness’ in psychiatric out-patients. Psychiatry Research, 127,283-287.
68. Parker, G., & Hadzi-Pavlovic, D. (1984). Modification of levels of depression in mother- bereaved women by parental and marital relationships. Psychological Medicine, 14(1), 125-135.
69. Parker, G., & Hadzi-Pavlovic, D. (Eds). (1996). Melancholia: A disorder of movement and mood. A phenomenological and neurobiological review. New York, NY: Cambridge University Press.
70. Parker, G., & Malhi, G. (2001). Are atypical antidepressant drugs also atypical antidepressants? Australian & New Zealand Journal of Psychiatry, 35, 631-638.
71. Parker, G., & Parker, K. (2003). Which antidepressants flick the switch? A review. Australian & New Zealand Journal of Psychiatry, 37,464-468.
72. Parker, G., & Roy, K. (2002). Examining the utility of a temperament model for modeling non-melancholic depression. Acta Psychiatrica Scandinavica, 106(1), 54-61.
73. Parker, G., Roy, K., Hadzi-Pavlovic, D., & Pedic, F. (1992). Psychotic (delusional) depression: a meta-analysis of physical treatments. Journal of Affective Disorders, 24(1), 17-24.
74. Parker, G., Hadzi-Pavlovic, D., Roussos, J., Wilhelm, K., Mitchell, P., Austin, M. P., et al. (1998a). Non-melancholic depression: the contribution of personality, anxiety and life events to subclassification. Psychological Medicine, 28(5), 1209-1219.
75. Parker, G., Gladstone, G., Roussos, J., Wilhelm, K., Mitchell, P., Hadzi-Pavlovic, D., et al. (1998b). Qualitative and quantitative analyses of a ‘lock and key’ hypothesis of depression. Psychological Medicine, 28(6), 1263-1273.
76. Parker, G., Gladstone, G., Mitchell, P., Wilhelm, K., & Roy, K. (2000). Do early adverse experiences establish a cognitive vulnerability to depression on exposure to mirroring life events in adulthood? Journal of Affective Disorders, 57(1-3), 209-215.
77. Parker, G., Hilton, T., Bains, J., & Hadzi-Pavlovic, D. (2001a). Cognitive-based measures screening for depression in the medically ill: The DMI-10 and DMI-18. Acta Psychiatrica Scandinavica, 105(6), 419-426.
78. Parker, G., Hilton, T., Hadzi-Pavlovic, D., & Bains, J. (2001b). Screening for depression in the medically ill: The suggested utility of a cognitive-based approach. Australian & New Zealand Journal of Psychiatry, 35, 474-480.
79. Parker, G., Hilton, T., Hadzi-Pavlovic, D., & Irvine, P. (2001c). Clinical and personality correlates of a new measure of depression: A general practice study. Australian & New Zealand Journal of Psychiatry, 37(1), 104-109.
80. Parker, G., Roy, K., Mitchell, P., Wilhelm, K., Malhi, G., & Hadzi-Pavlovic, D. (2002a). Atypical depression: a reappraisal. American Journal of Psychiatry, 159(9), 1480-1481.
81. Parker, G., Both, L., Olley, A., Hadzi-Pavlovic, D., Irvine, P., & Jacobs, G. (2002b). Defining disordered personality functioning. Journal of Personality Disorders, 16(6), 503-522.
82. Parker, G., Anderson, I. M., & Haddad, P. (2003a). Clinical trials of antidepressant medications are producing meaningless results. British Journal of Psychiatry, 183(2), 102-104.
83. Parker, G., Roy, K., & Eyers, K. (2003b). Cognitive behavior therapy for depression? Choose horses for courses. American Journal of Psychiatry, 160(5), 825-834.
84. Parker, G., Parker, K., Malhi, G., Wilhelm, K., & Mitchell, P. (2004). Studying personality characteristics in bipolar depressed subjects: how comparator group selection can dictate results. Acta Psychiatrica Scandinavica, 109(5), 376-382.
85. Parker, G., Brotchie, H., & Parker, K. (2005). Is combination olanzapine and antidepressant medication associated with more rapid movement in depression than use of antidepressant alone? The American Journal of Psychiatry, 162, 796-798.
86. Paykel, E. S. (1971). Classification of depressed patients: a cluster analysis derived grouping. British Journal of Psychiatry, 118(544), 275-288.
87. Peet, M. (2003). Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results. Prostaglandins Leukotrienes & Essential Fatty Acids, 69(6), 477-485.
88. Quinton, D., & Rutter, M. (1984). Parenting behaviour of mothers raised ‘In Care’. In A. R. Nicol (Ed.), Longitudinal studies in child psychology and psychiatry: Practical lessons from research experience. Chichester: Wiley Press.
89. Robinson, D. S., & Rickels, K. (1992). Concerns about clinical drug trials. Journal of Clinical Psychopharmacology, 20, 593-596.
90. Rodgers, B., Korten, A. E., Jorm, A. F., Jacomb, P. A., Christensen, H., & Henderson, A. S. (2000). Non-linear relationships in associations of depression and anxiety with alcohol use. Psychological Medicine, 30(2), 421-432.
91. Rutter, M. (1987). Temperament, personality, and personality disorder. British Journal of Psychiatry, 150,443-458.
92. Sachs, G. S., Koslow, C. L., & Ghaemia, S. N. (2000). The treatment of bipolar depression. Bipolar Disorders, 2, 726-733.
93. Segal, Z. V., Williams, J. M. G., & Teasdale, J. (2002). Mindfulness-based cognitive therapy for depression. A new approach to preventing relapse. New York, NY: The Guilford Press.
94. Seligman, M. E. (1972). Learned helplessness. Annual Review of Medicine, 207-412.
95. Seligman, M. E. (1975). Helplessness. On depression, development, and death.San Francisco, CA: WH Freeman and Company.
96. Shahar, G., Blatt, S. J., Zuroff, D. C., & Pilkonis, P. A. (2003). Role of perfectionism and personality disorder features in response to brief treatment for depression. Journal of Consulting & Clinical Psychology, 71 (3), 629-633.
97. Singh, N. A., Clements, K. M., & Fiatarone Singh, M. A. (2001). The efficacy of exercise as a long-term antidepressant in elderly subjects: A randomized, controlled trial. Journals of Gerontology: Series A: Biological Sciences & Medical Sciences, 56A(8), M497-M504.
98. Spiker, D. G., Weiss, J., Dealy, R., Griffin, S., Hanin, I., Neil, J., et al. (1985). The pharmacological treatment of delusional depression. American Journal of Psychiatry, 142(4), 430-436.
99. Stoll, A. L., Severus, E., Freeman, M. P., Rueter, S., Zboyan, H. A., Diamond, E., et al. (1999). Omega 3 fatty acids in bipolar disorder: preliminary double-blind, placebocontrolled trial. Archives of General Psychiatry, 56(5), 407-412.
100. Stuart, S., & Robertson, M. (2003). Interpersonal psychotherapy: a clinician's guide. London: Oxford University Press.
101. Svrakic, D. M., Whitehead, C., Przybeck, T. R., & Cloninger, C. (1993). Differential diagnosis of personality disorders by the seven-factor model of temperament and character. Archives of General Psychiatry, 50(12), 991-999.
102. Terman, M., & Terman, J. S. (1995). Treatment of seasonal affective disorder with highoutput negative ionizer. Journal of Alternative and Complementary Medicine, 1,87-92.
103. Terman, M., Terman, J. S., & Ross, D. C. (1998). A controlled trial of timed bright light and negative air ionization for treatment of winter depression. Archives of General Psychiatry, 55(10), 875-882.
104. Vollrath, M., Alnaes, R., & Torgersen, S. (1998). Coping styles predict change in personality disorders. Journal of Personality Disorders, 12(3), 198-209.
105. Walsh, B. T., Seidman, S. N., Sysko, R., & Gould, M. (2002). Placebo response in studies of major depression: Variable, substantial, and growing. Journal of the American Medical Association, 287(14), 1840-1847.
106. Widiger, T. A. (1998). Four out of five ain’t bad. Archives of General Psychiatry, 55(10), 865-866.
107. Williams Jr., J. W., Mulrow, C. D., Chiquette, E., Noel, P. H., Aguilar, C., & Cornell, J. (2000). A systematic review of newer pharmacotherapies for depression in adults: Evidence report summary. Annals of Internal Medicine, 132(9), 743-756.
108. Winokur, G. (1991). Mania and depression. A classification of syndrome and disease. Baltimore, MD: John Hopkins University Press.
109. World Health Organization. (1992). ICD-10. The ICD-10 classification of mental and behavioral disorders’ clinical descriptions and diagnostics guidelines (10th ed., revised). Geneva: World Health Organization.
110. World Health Organization. (1997). Composite International Diagnostic Interview 2.1. CIDI Interview Manual.
111. Zuroff, D. C., Blatt, S. J., Sotsky, S. M., Krupnick, J. L., Martin, D. J., Sanislow III, C. A., et al. (2000). Relation of therapeutic alliance and perfectionism to outcome in brief outpatient treatment of depression. Journal of Consulting & Clinical Psychology, 68(1), 114-124.